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Peterson and Morgan: The Huggins Test for Cancer and Related Protein Determination

The Huggins Test for Cancer and Related
Protein Determination
By HJALMER v. PETERSON AND HAROLD w. MORGAN
Due to the tremendous amount of research work being done on
cancer in recent years, a number of diagnostic tests have been
developed by different groups of individuals. One of the most
promising of the cancer detection methods utilizes the principle of
( 1) selective differentiation of blood sera by means of transmitted
filtered ultra violet light. Cancer sera transmit more light and
more fluorescence than normal or non-malignant sera, and the
fluorescence in cancer sera appears blue or violet; in non-malignant
sera the fluorescence is yellow or olive green. In 1800 sera, of
which 1600 were non-malignant, the percentage of false negatives
was about 14 per cent and the percentage of false positives was 4%.
Another test (2) is an easy one in which drops of blood from a
finger puncture are allowed to dry on a glass slide and viewed.
Non-malignant blood produces a dark mass centrally located in the
dried drop, whereas cancerous blood produces no centrally located
mass. Under the microscope non-malignant blood produces rouleau
formation with no variation in the size or shape of the red blood
corpuscles. Malignant blood produces no rouleau formation ; the
red blood cells are arranged in a disorderly fashion, abnormal in
size, shape, and arrangement. This test gave 96.5% correct results.
(3) A third test is the plasma methylene blue reducing time technique. One ml. of plasma (or serum) is placed in a Wasserman
tube and 0.2 ml. of specially standardized methylene blue solution
(0.15 per cent in distilled water) is added. After these are mixed,
the tubes are immersed in boiling water. A positive malignancy is
indicated if the methylene blue is not reduced in 10~ minutes. The
methylene blue reduction test is coupled with a heat turbidity index
test in which a ml. of plasma is placed in a photoelectric colorimeter
cuvette, diluted with 5 ml. of distilled water, mixed and the transmittancy read on the colorimeter. Theil the tube is immersed in
. boiling water for 10 seconds, cooled rapidly and a second transmittancy reading is taken. The difference between the two readings
is called the coagulation of turbidity value. The colorimeter is
standardized by using known malignant and non-malignant plasma
samples. In the use of these tests 89% of 468 malignant cases were
diagnosed correctly by either or both of the tests.
The last diagnostic test of note and the one on which this discussion will center is the ( 4) Thermal Coagulation of Serum Pro215
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tein test, or the so-called "Huggins Test," as developed by Huggins,
Miller and Jensen, of the University of Chicago. They demonstrated
that serum from cancer patients coagulated less readily than serum
from healthy individuals when heated in boiling water for 30
minutes. This difference in serum from cancer patients was more
accurately detected by the addition of iodoacetic acid which acted
as an inhibitor to coagulation at a pH of 7.4.
The mechanism of the inhibition of clot formation is unknown,
but it is thought that the iodoacetic acid reacts with these molecular
linkages in the protein which are essential to the formation of the
clot.
Eventually the investigators developed what they called the
iodoacetate index which is a mathematical expression relating the
inhibition of clotting by iodoacetic acid to the quantity of protein
present in the serum and thus to the total number of linkages in the
protein essential to coagulation. More specifically, the iodoacetate
index is the micro-moles of iodoacetic acid required to inhibit
coagulation of 1 milliliter of serum, divided by the total protein in
grams per cent.
The work that is about to be described was undertaken to determine the reliability of the Huggins test as a possible test for early
cancer in individuals. It was hoped that, if the test proved reliable,
it could be set up as a routine screening procedure for testing of
large numbers of individuals for cancer and thus identify malignancy
in its early stages so that effective treatment could be administered.
PROCEDURE

Reagents for Iodoacetic Acid Coagulation:
1. M/15 phosphate buffer, pH 7.4,-made by dissolving 1.743 gm.
potassium dihydrogen phosphate, KH 2 P0 41 and 7.652 gm. of
anhydrous disodium hydrogen phosphate, Na 2 HP0 4 , in water
and diluting to a liter.
2. Normal Sodium hydroxide.
3. 0.1 % phenol sulfone phthalein.
4. 0.06 M iodoacetic acid-made by dissolving 0.279 gm. recrystallized iodoacetic acid in 10 ml. of M/15 phosphate buffer to
which 2 drops of the 0.1 % phenolsulfonephthalein has been
added. To this is added enough normal sodium hydroxide, drop
to drop, to match the indicator color produced in 10 ml. of the
buffer solution alone. After matching, enough additional buffer
solution is added to make 25 ml. This solution is freshly prepared each day.
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5. 3M Sodium chloride.
Reagents of S eru111 Protein Determinations:

A. For micro-Kjeldahl determination:
1. 0.01 N hydrochloric acid.
2. 30% sodium hydroxide.
3. Mixed indicator - made up by mixing 10 parts of 0.1 % bromcresol green in 95% ethanol and 2 parts of 0.1 % methyl red in
95% ethanol in a bottle provided with a dropper drawn out to
a fine capillary (0.05 ml. per 4 drops.)
4. Copper sulfate - potassium sulfate mixture: 3 parts by weight
of copper sulfate pentahydrate, CuS0 4 • 5H
2 0 and one part by
weight of potassium sulfate, K 2 S0 41 thoroughly mixed and
ground in a mortar.
5. Selenium oxychloride.
6. 2% boric acid.
B. For Copper Sulfate-Specific Gravity method.

1. Saturated Copper Sulfate Solution at 23°C.
2. Stock Copper Sulfate Solution of Specific Gravity 1.100 made
by diluting 466 ml. of saturated solution to 1 liter.
3. Standard Copper Sulfate Solutions of Known Specific Gravities
between 1.018 and 1.030 specific gravities at intervals of 0.002prepared by measuring into a 100 ml. volumetric flask a volume
of stock solution less by 1 ml. than the value represented by the
second and third decimal places of the desired specific gravity
·and diluting the contents to 100 ml. These solutions were then
placed in 4 ounce bottles, labeled with the measured specific
gravities and tightly stoppered.
Determination of Serum Protein Content:

A. Micro-Kjeldahl method: (5)
A 2-5 mg. sample of serum was weighed to the nearest 0.1 mg.
into a porcelain microboat and the serum and boat were placed
into a large hard glass pyrex tube (25 x 200 mm.) which
served as a digestion flask. Three mg. of selenium oxychloride
and 5 mg. of the copper sulfate-potassium sulfate mixture were
added to the digestion flask, followed by 1 ml. of concentrated
sulfuric acid. The mixture was then digested over a microburner flame until the mixture cleared. After the tube was
cool, 2 ml. of distilled water were added to the digested sample ;
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after three or four minutes about 8 ml. of 30% sodium hydroxide were added and the tube was placed into a micro-Kjeldahl
distillation apparatus. Four drops of the mixed indicator were
added to 5 ml. of 2% boric acid in a SO ml. Erlenmeyer flask
which acted as the receiver. The tip of the condenser was
placed in the boric acid, and distillation with steam was started.
A color change of from bluish purple to blue green indicated
that the distillation was operating efficiently as soon as the
ammonia from the distillation came into contact with the boric
acid. About a minute after the first color change, the receiver
was lowered so that the condenser tip was about 1 cm above
the liquid and the distillation allowed to continue for about
another minute, after which the tip was washed with a little distilled water. Titration with the 0.01 N hydrochloric acid was
then carried out - the end point being a disappearance of the
blue color of the indicator. The protein content was estimated
by multiplying the total nitrogen content minus the non-protein
nitrogen content (determined separately) by 6.25.
B. The Copper Sulfate-Specific Gravity method: (6)
(After running many micro-K jeldahl protein determinations
we soon discovered that the method was time consuming. If
the Huggins test were going to be run in large numbers, a
shorter, reliable test for proteins should be developed. The
copper sulfate-specific gravity method was tried and found to
give fairly consistent protein results in comparison with the
micro-Kjeldahl technique.)
In this method, serum was drawn into an eye dropper with
a drawn out tip, and a small drop was allowed to fall by gravity
from a height of about 1 cm. above the solution into one of the
standard copper solutions of known specific gravity. The behavior of the drop \vas closely observed for about 10 seconds
after it had lost the momentum of its fall. If the drop rose
during the 10 second period, it was lighter than the test solution; if it continued to fall, it was heavier; if it remained stationary, it had the same specific gravity as the solution. If the
specific gravity of the drop was not ascertained by the first
test, the procedure was repeated on solutions of higher or lower
specific gravity until a solution was found in which the drop
remained stationary, which gave the specific gravity of the
serum, or there were two adjacent standards, in one of which
the drop rose and in the other it fell. In this case interpolation
between the values of the two standards was made. From the
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determined specific gravity, results were obtained by reference
to the line chart accompanying the description of the method.
Table 1 shows our results as to the comparison of serum
protein values when analyzed by the two different methods of
determination.
Table I
Comparison of Micro-Kjeldahl and Copper Sulfate-Specific Gravity
Serum Protein Determinations in Grams Per Cent
Case Number

Micro-Kjeldahl Method

Copper Sulfate Method

105

6.71
7.12
6.09
6.66
6.59
7.15
6.73
6.93
7.08
6.73
6.51
7.18

6.70
7.12
5.90
6.60

106
107
108
109
111
115
120
124
126
127

131

6.70
7.12
6.70
6.95
7.12
6.93
6.62
7.10

The average difference between the results of the two methods on 27 different sera, including those listed above, was 0.07
grams percent. No clinically significant change in the results
of the Huggins test was evidenced by this small difference in
the protein values.
After learning that the two methods gave close results, we
decided that the copper sulfate-specific gravity method of serum
protein determination would be used for all subsequent Huggins
tests. If, in the final calculation, it was found that a blood could
be either positive or negative for cancer by a slight variation in
the serum protein determination, then a micro-Kjeldahl determination would be run and its result used in the calculation.
Determination of Iodoacetic Acid Index:
The reagents, the tube set up, and the method and equipment used to determine the iodoacetate index, were exactly the
same as used. by the authors of the method. The preparation
of the necessary reagents for the determination was described
earlier in this report. The arrangement of the tubes, volumes
of the various reagents and the final concentration of the
iodoacetic acid in each tube are found in the following table :
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Table 2
Tube No.

2

3

4

s

6

7

8

9

10

Serum, ml.
0.2S 0.2S 0.2S 0.2S 0.2S 0.2S 0.2S 0.2S 0.2S 0.2S
Sodium Chloride,
.I2
3M, ml.
.12 .12 .12 .I2 .12 .I2
.12 .12
.I2
Buffer, ml.
.23 .20 .I8 .IS
.I3
.10 .08 .OS
.00
.03
Iodoacetic Acid, ml. .IS
.2S
.28
.30 .33
.38
.I8 .20 .23
.3S
Concentration of
Iodoacetic Acid uM 9.0 10.8 I2.0 I3.8 IS.O I6.8 I8.0 19.8 21.0 22.8

After the tubes were removed from the boiling water, by
the authors' definition, serum was coagulated when it was thoroughly solid and would not pour when it was inverted and
gently rotated. The end point was the concentration of the
iodoacetic acid in the last tube in the series which showed
coagulation. This tube's iodoacetic acid concentration multiplied by four and divided by the protein content of the serum
in grams per cent gave the iodoacetate index of the serum.
(The authors later developed a different technique (7) for
determining the end point. A fine wire loop of stiff wire no. 8, piano wire - was made to fit closely the inside of the
tubes. This was thrust to the bottom of the tubes and withdrawn. The tubes were then inverted to a 45 degree angle. If
the contents of a tube remained in the end of the tube or slid
down the tube as a well defined mass, the tube was read
"coagulated.")

In their original work, the investigators chose the iodoacetate
index of 9.00 as the dividing line between positive and negative
tests for cancer because that number excluded all tests run on
healthy persons in the first series of 283 tests, in which there were
16 patients with non-malignant pathology, 85 patients with cancer,
and the remainder healthy individuals. All tests run on cancer
patients gave results for the index below 9.00; all healthy individuals gave results above 9.00. For this reason we chose the iodoacetic
acid index of 9.00 as the dividing line between positive and negative
cancer tests.
Results:
Out of 31 known cases of cancer, 24 had iodoacetate indices
of less than 9.00. Thus, using 9.00 as the dividing line between
positive and negative tests for cancer, correct results were obtained in 77.4% of the cases.
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Out of 42 non-malignant cases tested, 24 had indices of less
than 9.00. (Many of these cases and the diagnosis are listed
in Table III. The correct diagnosis was not obtainable on the
remainder.)
Most of the normal cases in Table III came from the Mason
City, Iowa, Blood Bank, and we assumed that the individuals
donating blood were free from cancer. Out of 170 normal
cases, 3 had iodoacetate indices of less than 9.00. There was
no possibility of checking the three individuals for possible
cancer symptoms.
Table 3
Iodoacetate Index and Diagnosis of Patients
with Noncancerous Diseases.
Case No.
8
14
16

23
70
81
lll
208
233
243
244
245
246
249
250
251

Diagnosis

Iodoacetate Index

Acute appendix
Gall bladder infection
Ulcerative prostatitis
Arteriosclerotic occlusive
Lung tuberculosis
Acute appendix
Cervicitis
Fibroids
Abdominal hysterectomy
3rd degree burn
Multiple fractures
Fracture of os calsis
Fracture of tibia
Hemorrhoids
Acute pancreatitis
Ruptured L-5 disc

6.52
7.09
6.59
6.43
6.35
8.98
8.42
8.50
7.74
6.86
6.17
8.13
7.20
8.24
7.00
8.69

SUMMARY

The thermal coagulation of serum protein test, so-called Huggins
Test, was run on 243 individuals. Thirty-one of these individuals
had proven cancer; 42 had non-malignant pathology; and 170
were presumably normal individuals.
It was found (a) that correct results were obtained in 77.4 per
cent of the cases with proven cancer, (b) that 57.3 per cent of the
test run on noncancerous patients gave iodoacetate index results
that were lower than 9.00 and thus would be in the cancerous
range, ( c) that three individuals out of 170 apparently normal
individuals had iodoacetate indices lower than 9.00 - about 1.8%
of the total.
On the basis of this data it is logical to assume that the thermal
coagulation test is not specific enough for cancer and therefore
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Iodoacetate Index
Distribution of iodoacetate indices in normal, healthy individuals; non-malignant cases
with no proven cancer; and patients with cancer.
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would not be satisfactory as a screen test for early cancer m
individuals.
For most clinical purposes, the copper sulfate-specific gravity
method of determining serum proteins is satisfactory, inasmuch as
its results are very close to the results obtained from micro-Kjeldahl
determinations.
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